The Citrus Research and Field Trial (CRAFT) Foundation has reopened the application window for its Existing Tree Therapies Program. Applications will be accepted until 5 p.m. on Aug. 31. Participants will be selected through a random lottery, administered by a third-party entity. The program is designed to provide the industry with a better understanding of the best use patterns, combinations and …
Angle Recognizes Urgency of HLB Research
Scott Angle, University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) senior vice president for agriculture and natural resources, began the educational session during the Florida Citrus Industry Annual Conference with a message of urgency. He recognized the critical threat posed by HLB and said science could catch up to the problem. “Plant sciences are advancing globally at almost the speed …
Moving Forward With a New HLB Treatment
By Peter Chaires I am a big fan of Robert Fulghum’s famous book titled “All I Really Need to Know I Learned in Kindergarten.” This little gem started out with lightweight calls to play fair and wash your hands before you eat. But soon it turned up the heat and waxed somewhat philosophical with a couple heavy hitters. One of …
Rectify Injection Available for HLB in Florida
FEBRUARY 21, 2023 HLB MANAGEMENT, INDUSTRY NEWS RELEASE, PESTICIDES Rectify, AgroSource, Inc.’s 95% oxytetracycline hydrochloride-based tree-injection product, is expected to be available for use against HLB in Florida citrus as early as Feb. 24. The product will be available to growers through existing commercial agricultural product distributors. AgroSource petitioned and received a Special Local Needs (SLN) approval for Rectify by the Florida Department of Agriculture …
Tracking HLB in Georgia
When commercial citrus acreage started migrating north some years ago, the big question was: To what extent would Asian citrus psyllids (ACP) and HLB migrate with the crop? With citrus getting well established in South Georgia, the pest and disease are there, but not yet at devastating levels like in Florida. Johnathan Oliver, an assistant professor of fruit pathology with …
Guidance Provided on Use of ReMedium TI
Trunk injection of the oxytetracycline hydrochloride formulation ReMedium TI for HLB treatment was given final clearance Jan. 11. The product began moving into the Florida citrus industry that same day. Consequently, the product’s manufacturer and the Citrus Research and Field Trial (CRAFT) Foundation both issued reminders and recommendations about the product’s use. Manufacturer TJ BioTech, LLC suggested the following things for growers …
CRDF Allocates Year-End Funds to HLB Research Projects
The Citrus Research and Development Foundation (CRDF) met for its December board meeting to discuss several topics before heading into the new year. One of the bigger areas of discussion was what to do with available uncommitted funds. “The board decided to fund work on several questions growers have regarding the use of bactericides inserted through systemic delivery devices and give the …
Trunk Injection Soon to Become Reality in Florida Citrus
The Gulf Citrus Growers Association (GCGA) hosted a luncheon on Dec. 7 at the Southwest Florida Research and Education Center featuring a presentation by Tom Johnson, chief executive officer of TJ BioTech. The company is the manufacturer of ReMedium TI, the widely discussed formulation of oxytetracycline hydrochloride (OTC-HCI) that has shown promise as a treatment for HLB. The product is …
Citrus Trunk Injection Product Registered for Use
The Florida Department of Agriculture and Consumer Services (FDACS) on Oct. 28 granted a 24(c) special local need registration for the citrus trunk injection of ReMedium TI for the control or suppression of HLB. The TJ BioTech product is oxytetracycline (OTC) hydrochloride, an antibiotic. “EPA (the federal Environmental Protection Agency) has 90 days to object, but it is my understanding …
Citrus Trunk Injection Detailed at Meeting
What may be the closest thing yet to a timely silver bullet for HLB was discussed Oct. 26 at Lake Alfred’s Citrus Research and Education Center. Josh Steinbronn, director of research and development at TJ BioTech, said trunk injection of his company’s ReMedium TI oxytetracycline product suppresses Candidatus Liberibacter asiaticus (CLas), the causal agent of HLB. He added that injection of the product significantly …